로딩 중…
지수 로딩 중…
MBX Biosciences, Inc. Common Stock
MBX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$64.35-2.40%
2026-08-03
Financials
Valuation Metrics
MBX Biosciences, Inc. Common Stock's Market Cap is $3.06B. At end of 2025 it was $1.15B. Ranked #1751 of 3,112 in US market (top 56%), #624 of 1,445 on NASDAQ (top 43%), #104 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 39%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $3.06B | US#1,751/3,112 Sec#104/269 |
| Revenue | $0.00 | US#2,974/3,112 Sec#204/269 |
| Net Income | $-87M | US—/3,112 Sec—/269 |
| Total Assets | $453M | US#2,780/3,112 Sec#170/269 |
| Net Assets | $438M | US#2,353/3,112 Sec#126/269 |
| Value | ||
| P/B | 7.00x | US#2,419/3,112 Sec#175/269 |
| FCF Yield | -2.61% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -19.78% | US#2,521/3,112 Sec#101/269 |
| ROA | -19.13% | US#2,765/3,112 Sec#123/269 |
| Financial Health | ||
| Debt Ratio | 3.41% | US#28/3,112 Sec#6/269 |
| Total Debt | $555000.00 | US#2,949/3,112 Sec#257/269 |
| FCF | $-80M | US#2,544/3,112 Sec#136/269 |
| Cash | $45M | US#2,622/3,112 Sec#233/269 |
| Current Ratio | 30.79x | US#81/3,112 Sec#9/269 |
| Performance | ||
| 1Y Return | 368.00% | US#24/3,112 Sec#13/269 |
| 1M Return | 11.33% | US#454/3,112 Sec#19/269 |
| From 52W High | -7.28% | US#779/3,112 Sec#31/269 |
| 1Y MDD | -37.12% | US#1,812/3,112 Sec#130/269 |
| Trading | ||
| Volume | 323,679 shares | US#2,372/3,112 Sec#230/269 |
| Trading Value | $21M | US#1,934/3,112 Sec#142/269 |
| Per Share | ||
| EPS | $-2.38 | US—/3,112 Sec—/269 |
| BPS | $10.11 | US#1,776/3,112 Sec#62/269 |